Vyvanse and Skin - clammy - a phase IV clinical study of FDA data
Summary:
Skin - clammy is reported as a side effect among people who take Vyvanse (lisdexamfetamine dimesylate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Dalfampridine, and have Gait disturbance.
The phase IV clinical study analyzes which people have Skin - clammy when taking Vyvanse. It is created by eHealthMe based on reports of 28,083 people who have side effects when taking Vyvanse from the FDA, and is updated regularly.
What is Vyvanse?
Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 35,868 Vyvanse users. Check the latest studies of Vyvanse.
What is Skin - clammy?
Skin - clammy is found to be associated with 1,127 drugs and 1,709 conditions by eHealthMe. Check the latest studies of Skin - clammy.
28,083 people reported to have side effects when taking Vyvanse.
Among them, 42 people (0.15%) have Skin - clammy.

Among these 42 people:
How long have people been on Vyvanse when they have Skin - clammy? *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Skin - clammy when taking Vyvanse? *
- female: 72.5 %
- male: 27.5 %
What is the age of people who have Skin - clammy when taking Vyvanse? *
- 0-1: 0.0 %
- 2-9: 5.71 %
- 10-19: 5.71 %
- 20-29: 28.57 %
- 30-39: 14.29 %
- 40-49: 11.43 %
- 50-59: 5.71 %
- 60+: 28.57 %
What are other drugs people take besides Vyvanse? *
- Dalfampridine: 9 people, 21.43%
- Xyrem: 8 people, 19.05%
- Synthroid: 6 people, 14.29%
- Levothyroxine Sodium: 5 people, 11.90%
- Ocrevus: 4 people, 9.52%
- Elinest: 3 people, 7.14%
- Zofran: 3 people, 7.14%
- Humira: 3 people, 7.14%
- Klonopin: 3 people, 7.14%
- Evekeo: 3 people, 7.14%
What are other side effects people have besides Skin - clammy? *
- Nausea (feeling of having an urge to vomit): 14 people, 33.33%
- Hyperhidrosis (abnormally increased sweating): 13 people, 30.95%
- Drug Ineffective: 13 people, 30.95%
- Loss Of Consciousness: 13 people, 30.95%
- Stress And Anxiety: 11 people, 26.19%
- Gait Disturbance: 10 people, 23.81%
- Fatigue (feeling of tiredness): 10 people, 23.81%
- Memory Loss: 10 people, 23.81%
- Weakness: 10 people, 23.81%
- Fall: 10 people, 23.81%
What are the existing conditions these people have? *
- Gait Disturbance: 9 people, 21.43%
- Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 8 people, 19.05%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 16.67%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 11.90%
- High Blood Pressure: 3 people, 7.14%
- Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 4.76%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 4.76%
- Insomnia (sleeplessness): 2 people, 4.76%
- Psychotic Disorder: 1 person, 2.38%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 2.38%
* Approximation only. Some reports may have incomplete information.
Do you take Vyvanse and have Skin - clammy?
- Check whether Skin - clammy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Vyvanse:
- Vyvanse (35,868 reports)
Skin - clammy treatments and more:
- Skin - clammy (19,745 reports)
How severe was Skin - clammy and when was it recovered:
Expand to all the drugs that have ingredients of lisdexamfetamine dimesylate:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Vyvanse:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Skin - clammy:
- Skin - clammy (1,127 drugs)
Browse all the conditions that are associated with Skin - clammy:
- Skin - clammy (1,709 conditions)
Related publications that referenced our studies
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on lisdexamfetamine dimesylate (the active ingredients of Vyvanse) and Vyvanse (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Oral Contraception and Migraine - 5 seconds ago
- Could Tegretol cause Malnutrition? - 6 seconds ago
- Could Xeljanz cause Effusion? - 11 seconds ago
- Faeces Hard and Stroke - 24 seconds ago
- Drug interactions of Fluoride and Bactrim - 25 seconds ago
- Could Ramelteon cause Weakness? - 39 seconds ago
- Could Wellbutrin cause Application Site Scar? - 52 seconds ago
- Could Leucovorin Calcium cause Abdominal Pain? - 57 seconds ago
- Could Alendronic Acid cause Progressive Multifocal Leukoencephalopathy? - a minute ago
- Could Paxil Cr cause Death? - a minute ago